StockData
EoCene Ltd. logo

EoCene Ltd. (EOCN) stock

EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 31, 2026Score 5/30
$2.20−0.26 (-10.63%)

Close on Nov 18, 2026Market cap $2.20MP/E –Yield –

EoCene net income

Net income is the profit left for shareholders after every expense, interest and tax.

EoCene's net income for the twelve months ending Jun 30, 2026 was -$11.34M. For fiscal 2025 it was -$10.31M. The highest annual figure on record is -$6.91M in fiscal 2023.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.31M–
FY2024Dec 31, 2024-$7.52M–
FY2023Dec 31, 2023-$6.91M–
FY2022Dec 31, 2022-$17.87M–
FY2021Dec 31, 2021-$32.47M–
FY2020Dec 31, 2020-$28.77M–
FY2019Dec 31, 2019-$20.46M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.72M–
Q1 FY2026Mar 31, 2026-$1.91M–
Q4 FY2025Dec 31, 2025-$4.82M–
Q3 FY2025Sep 30, 2025-$1.89M–
Q2 FY2025Jun 30, 2025-$2.50M–
Q1 FY2025Mar 31, 2025-$1.10M–
Q4 FY2024Dec 31, 2024-$3.21M–
Q3 FY2024Sep 30, 2024-$1.91M–
Q2 FY2024Jun 30, 2024-$1.12M–
Q1 FY2024Mar 31, 2024-$1.28M–
Q2 FY2023Jun 30, 2023-$1.59M–
Q1 FY2023Mar 31, 2023-$1.83M–
Q2 FY2022Jun 30, 2022-$3.73M–
Q1 FY2022Mar 31, 2022-$6.14M–
Q2 FY2021Jun 30, 2021-$8.40M–
Q1 FY2021Mar 31, 2021-$8.91M–
Q2 FY2020Jun 30, 2020-$5.53M–
Q1 FY2020Mar 31, 2020-$6.06M–

More EoCene figures

See a number that looks wrong?